Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: Is an additional vaccine needed or possible?

This publication has 18 references indexed in Scilit:

• RNAIII-inhibiting Peptide and/or Nisin Inhibit Experimental Vascular Graft Infection with Methicillin-susceptible and Methicillin-resistant Staphylococcus epidermidis
  European Journal of Vascular and Endovascular Surgery, 2004
• Vaccination with Nontoxic Mutant Toxic Shock Syndrome Toxin 1 Protects againstStaphylococcus aureusInfection
  The Journal of Infectious Diseases, 2003
• The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections
  Current Opinion in Infectious Diseases, 2003
• Epidemiological and Microbiological Characterization of Infections Caused byStaphylococcus aureuswith Reduced Susceptibility to Vancomycin, United States, 1997–2001
  Clinical Infectious Diseases, 2003
• Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus
  Proceedings of the National Academy of Sciences, 2002
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• Immunization with Alpha-Toxin Toxoid Protects the Cornea against Tissue Damage during Experimental Staphylococcus aureus Keratitis
  Infection and Immunity, 2000
• Role of Teichoic Acid in the Binding of Staphylococcus aureus to Nasal Epithelial Cells
  The Journal of Infectious Diseases, 1980
• Recurrent staphylococcal infection in families
  Archives of Dermatology, 1980
• BACTERIAL INTERFERENCE BETWEEN STRAINS OF S. aureus
  Annals of the New York Academy of Sciences, 1974